Umbilical Cord Mesenchymal Stem Cells Transplantation in the Treatment of Bronchopulmonary Dysplasia
NCT04062136 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 10
Last updated 2024-06-04
Summary
To evaluate the safety and efficacy of human umbilical cord mesenchymal stem cells transplantation in patients with bronchopulmonary dysplasia
Conditions
- Bronchopulmonary Dysplasia
Interventions
- COMBINATION_PRODUCT
-
stem cell transplantation
Transplantation of umbilical cord mesenchymal stem cells
Sponsors & Collaborators
-
Vinmec Research Institute of Stem Cell and Gene Technology
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 1 Month
- Max Age
- 6 Months
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-03-01
- Primary Completion
- 2020-11-30
- Completion
- 2020-11-30
Countries
- Vietnam
Study Locations
More Related Trials
-
Cellular Therapy for Extreme Preterm Infants at Risk of Developing Bronchopulmonary Dysplasia
NCT04255147 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
PNEUMOSTEM for the Prevention and Treatment of Severe BPD in Premature Infants
NCT03392467 ·Status: COMPLETED ·Phase: PHASE2
-
Budesonia + Intratracheal Surfactant in Incidence of Bronchopulmonary Dysplasia
NCT05534685 ·Status: UNKNOWN ·Phase: NA
-
The Efficacy and Safety of Montelukast Sodium in the Prevention of Bronchopulmonary Dysplasia
NCT01717625 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of Adding Budesonide to Poractant Alfa to Prevent Bronchopulmonary Dysplasia.
NCT03521063 ·Status: UNKNOWN ·Phase: PHASE4
-
Follow-Up Study of Safety and Efficacy of Pneumostem® in Premature Infants With Bronchopulmonary Dysplasia
NCT01632475 ·Status: ACTIVE_NOT_RECRUITING
-
CPAP for Infantile Pompe Disease
NCT02405624 ·Status: UNKNOWN ·Phase: PHASE4
-
Little Lungs Study
NCT06855043 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Intratracheal Budesonide With Surfactant to Prevent Bronchopulmmonary Dysplasia.
NCT04862377 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Inhaled Beclomethasone to Prevent Chronic Lung Disease
NCT00000576 ·Status: COMPLETED ·Phase: PHASE3
-
Implementation of a Consensus-Based Discharge Protocol for Preterm Infants With Lung Disease
NCT05285345 ·Status: RECRUITING
-
Pilot Study of Topical Steroid for Prevention of Chronic Lung Disease in Extremely Premature Infants.
NCT01268215 ·Status: UNKNOWN ·Phase: PHASE2
-
Steroids and Surfactant in Extremely Low Gestation Age Infants Dose Escalation Trial
NCT02907593 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
PK, Safety and Preliminary Efficacy Study of Montelukast in Critically Ill Infants With Developing Bronchopulmonary Dysplasia
NCT07101640 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
A Safety and Efficacy Study of Lucinactant for Inhalation in Preterm Neonates 26 to 32 Weeks Gestational Age
NCT04264156 ·Status: TERMINATED ·Phase: PHASE2
-
A Clinical Efficacy and Safety Study of OHB-607 in Preventing Bronchopulmonary Dysplasia in Extremely Premature Infants
NCT03253263 ·Status: RECRUITING ·Phase: PHASE2
-
Efficacy and Safety of Inhaled Budesonide in Very Preterm Infants at Risk for Bronchopulmonary Dysplasia
NCT01035190 ·Status: COMPLETED ·Phase: PHASE3
-
Budesonide With Intratracheal Surfactants in Extremely Preterm Infants
NCT04019106 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Intra-tracheal Instillation of Budesonide to Prevent Chronic Lung Disease
NCT05364385 ·Status: UNKNOWN ·Phase: PHASE4
-
Advancement of Modified Bubble CPAP
NCT02208323 ·Status: COMPLETED ·Phase: PHASE2
-
Aerosolized Albuterol Use in Severe BPD
NCT02766673 ·Status: COMPLETED ·Phase: NA
-
The Effect of Bethanechol on Tracheobronchomalacia
NCT05299008 ·Status: RECRUITING
-
Treatment of Pediatric Bronchiolitis Obliterans by Airway Basal Stem Cells
NCT07239895 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Intratracheal Budesonide/Surfactant Prevents BPD
NCT03275415 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluating the Safety and Performance of the MiniLung Petite Kit in Neonatal and Pediatric Patients With Acute Respiratory and Cardiac Failure
NCT06750536 ·Status: RECRUITING